📖
Donafenib suppresses glioblastoma progression: potential enhancement of therapeutic response in TMZ-resistant models.
Yazici E, Gezen A, Kalay M, Kocak O, Oylumlu E, Simsek E, Tanriover G

Donafenib suppresses glioblastoma progression: potential enhancement of therapeutic response in TMZ-resistant models.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Naunyn Schmiedebergs Arch Pharmacol.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Donafenib suppresses glioblastoma progression: potential enhancement of therapeutic response in TMZ-resistant models.
Author / Organization Yazici E, Gezen A, Kalay M, Kocak O, Oylumlu E, Simsek E, Tanriover G
Subject & Discipline Naunyn Schmiedebergs Arch Pharmacol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-6343
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »